CommercialCoverageMedium impact
08.00.13ak, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)
Independence Blue Cross·Allergy & Immunology, Neurology, Hematology +3 more·Medical Policy
Effective date
Jan 1, 2025
We identified it
Jun 19, 2026
Summary
The Immune Globulin Intravenous (IVIG) and Subcutaneous (SCIG) medical policy has been updated for commercial insurance plans. This policy change affects coverage and billing requirements for immunoglobulin treatments, which are high-cost therapies requiring specific medical necessity documentation.
Action Required
By January 31, 2025: Billing team must review the updated IVIG/SCIG policy at the provided URL to identify specific coverage changes, prior authorization requirements, and documentation standards. Update billing procedures and notify providers of any new medical necessity requirements for immunoglobulin treatments.